Dermaxon LLC
Missoula, MT Dermaxon LLC
- UEI
- R33ESK4L9GG3
- CAGE
- 6VL04
- Primary NAICS
- Not on record
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- SAM.gov registration date
- Physical address
- 6610 Justin Ct, Missoula, MT 59803, USA
- Website
- dermaxon.com
- Founded
- 2013
- Employees
- 1-10
- Estimated annual revenue
- $0-$1M
- Industry
-
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- Biotechnology
- SIC code
- 28 Chemical & Allied Products
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Recent federal awards
About Dermaxon LLC
Dermaxon LLC is a biotech company registered in Missoula, Montana, specializing in pharmaceutical research and development with a focus on dermatological and sensory disorders. Established and registered in the System for Award Management (SAM.gov) in March 2013, the company is classified as a minority-owned, for-profit limited liability company with a Hispanic American ownership structure. The organization has demonstrated expertise in developing targeted molecular interventions for complex medical conditions, particularly in areas related to skin diseases, hearing loss, and inflammatory disorders.
Through its federal grant awards, Dermaxon LLC has pursued innovative research in multiple therapeutic domains, primarily focused on developing novel molecular inhibitors and interventions. The company has received significant research grants from prominent National Institutes of Health (NIH) agencies, including the National Institute on Deafness and Other Communication Disorders, the National Institute of Arthritis and Musculoskeletal and Skin Diseases, and the National Center for Advancing Translational Sciences. These grants have supported groundbreaking research projects, such as developing a selective CYP26 inhibitor (DX308) for treating noise-induced hearing loss, exploring oral treatments for recalcitrant nodular acne, and investigating a topical therapeutic approach for cutaneous lupus erythematosus. Dermaxon collaborates with academic research institutions like the University of Texas Medical Branch and the University of Montana, leveraging interdisciplinary expertise to advance its scientific objectives. The company's research approaches consistently demonstrate a sophisticated understanding of molecular pathways, focusing on targeted interventions with potential to minimize side effects and improve patient outcomes across various medical conditions.
Quick answers
What is Dermaxon LLC's UEI?
Dermaxon LLC's Unique Entity ID (UEI) in SAM.gov is R33ESK4L9GG3.
What is Dermaxon LLC's CAGE code?
Dermaxon LLC's CAGE code is 6VL04.
Where is Dermaxon LLC located?
Dermaxon LLC's physical address in SAM.gov is 6610 Justin Ct, Missoula, MT 59803, USA.
Is Dermaxon LLC registered in SAM.gov?
Yes. Dermaxon LLC's SAM.gov registration is active through August 21, 2027.
What is Dermaxon LLC's most recent federal award?
Dermaxon LLC's most recent federal grant award is Targeting retinoid acid metabolic pathways to treat noise-induced hearing loss - project summary noise-induced hearing… (R41DC021394), from National Institute on Deafness and Other Communincation Disorders, on June 1, 2024.
On GovTribe
See Dermaxon LLC's full federal record
- Federal grant awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors